HALO Halozyme Therapeutics, Inc. logo

HALO Halozyme Therapeutics, Inc.

Healthcare
$68.32-0.29%ClosedMarket Cap: $8.10B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

623

13F Shares

123,140,038

Ownership %

105.1%

New Positions

102

Increased Positions

317

Closed Positions

95

Reduced Positions

225

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
LSLTPacer Salt Low truBeta US Market ETF925,4123.81%
SLTPacer Salt High truBeta US Market ETF925,4123.81%
VIRS925,4123.81%
VETS925,4123.81%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF925,4123.81%
LSATLeaderShares AlphaFactor Tactical Focused ETF27,8793.00%
FFLSThe Future Fund Long/Short ETF18,1302.86%
PBEInvesco Biotechnology & Genome ETF99,8802.59%
CSMDCongress SMID Growth ETF161,1302.37%
EWMCInvesco S&P MidCap 400 Equal Weight ETF162,7662.25%
GRPMInvesco S&P MidCap 400 GARP ETF162,7662.25%
RFGInvesco S&P MidCap 400 Pure Growth ETF89,3451.90%
BBPVirtus Biotech ETF13,5711.66%
COWGPacer US Large Cap Cash Cows Growth Leaders ETF522,8991.50%
CANCTema Oncology ETF32,1781.24%
FFNDOne Global ETF17,4421.23%
AFTYPacer CSOP FTSE China A50 ETF29,7651.18%
XBI1,274,4891.14%
VALT28,2641.13%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF135,0491.08%